Aptar Pharma, a world leader in innovative drug delivery systems, is pleased to announce the approval by the European Medicines Agency (EMA) of the first integrated electronic nasal lockout device (e-Lockout) following a multi-year development with Takeda

Aptar Pharma’s site expansion in Congers, NY was inaugurated on March 20th by Stephan Tanda, AptarGroup’s President and CEO, Salim Haffar, President of Aptar Pharma, and Alex Theodorakis, President Aptar Pharma North America. Several Aptar Pharma customer

Aptar Pharma presented a range of new Integrated Connected Inhalers during the scientific event Drug Delivery to the Lungs (DDL) held in Edinburgh Dec. 7-9, 2016.
The event follows the announcement made in February 2016 about the Aptar Pharma and Propelle

Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the U.S. prescription market for the first time with Allergan’s RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05%.

Thi

On March 14, people from around the world participated in Aptar Pharma’s live webinar “Growing Confidence in Airless Dispensing”.

Aptar Pharma experts, Dr. Stefan Hellbardt and Thomas Hauser, led the webinar, and outlined in detail the principles and ben

With integrated label verification technology and Operational Intelligence software, the PX940 industrial printer gives customers error-free printing, predictive analytics, and a lower overall cost of ownership.

Dolphin CT40, Mobile Computer. Built on the future-proof Mobility Edge platform, the sleek and versatile Dolphin CT40 mobile computer enables retail associates and highly mobile workers to increase productivity and deliver a seamless customer experience t

A global pharmaceutical company improved output speed for 4-side-seal sachets of powders by selecting a new packaging line—complete with remote installation. The system can compact stacks of sachets before transferring them to the cartoning machine.

New Salemti Guide